Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer
Zibing Wang(Huazhong University of Science and Technology), Yongping Song(Zhengzhou University), Quanli Gao(Zhengzhou University), Rui’e Li(Zhengzhou University), Lingdi Zhao(Zhengzhou University), Changfu Nie(Zhengzhou University), Tiejun Yang(University of Pittsburgh), Yong Zhang(Institute of Pomology), Wěi Li(Shougang (China)), Ying Liu(Chongqing University), Suxia Luo(Zhengzhou University), Yuqing Liu(Central South University), Feng Han(Zhengzhou University), Xiaojie Zhang(Hangzhou Red Cross Hospital), Yonghao Yang(Army Medical University), Yiman Shang(Henan Cancer Hospital)
Cited by 34
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
HIF-1α pathway: role, regulation and intervention for cancer therapy
|Acta Pharmaceutica Sinica B|2015|1.9k
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
|Molecular Cancer|2019|1.2k